Infection and its role in the causes of preterm birth


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

In recent years, the results of a number of studies on the problem of preterm birth have been published. It supposed that the rate of preterm birth should have reduced. Despite this, infection factors still contribute significantly to the structure of the causes of preterm birth. The aim of our study was to determine the role of infection in the structure of premature birth causes. A retrospective analysis of the course of pregnancy, delivery, complications in children at a level 1 unit was carried out in 276 patients with a gestational age of 22.0 to 34.6 weeks. Special attention was paid to various methods of infection diagnosis and its influence on the mother and fetus. Upon admission to the hospital, all patients underwent an assessment of the flora of the vagina and cervical canal by the bacterioscopic and cultural method, also by the method of polymerase chain reaction (qualitative PCR). To identify the role of infection in the genesis of extremely preterm birth in 196 (71.0%) children from 22.0 to 27.8 weeks, the bacterial spectrum of the flora was studied (sampling of material from the pharynx, anus; blood culture), a morphological study of the placentas was carried out. In preterm labor complicated by preterm premature rupture of membranes, a high rate (88.7%) of intrauterine infection and the presence of signs of inflammation (92.3%) in fetuses was revealed during post mortem examination. Analyzing the infection factor in newborns, in 81.6% opportunistic (58.8%) and pathogenic (41.2%) flora was detected. At the same time, only 36.0% showed a correspondence between the identified flora in mothers and children. In the absence of pathological flora and clinical symptoms of infection in the mothers 22.6% of children were born with intrauterine infection. It was noted that among the patients with the onset of preterm labor, in most of the results (91.2%), there was no lactobacilli domination that heads antimicrobial protection, while normally in the vaginal microbiota their number should reach up to 80.0%. It was shown that in order to objectify the infection factor in the genesis of preterm labor, it is necessary to introduce a new method for identifying the specific representatives of normo- and opportunistic vaginal biota - polymerase chain reaction (with real-time detection). Along with antibiotics, probiotics should be included in the treatment of preterm labor.

Full Text

Restricted Access

About the authors

R. I Shalina

Pirogov Russian National Research Medical University

Professor

D. S Spiridonov

Pirogov Russian National Research Medical University

Email: spiridonov_ds@rsmu.ru
Candidate of Medical Sciences

E. R Plekhanova

Pirogov Russian National Research Medical University

Candidate of Medical Sciences

L. E Breusenko

Pirogov Russian National Research Medical University

Candidate of Medical Sciences

Ya. S Borisov

Pirogov Russian National Research Medical University

References

  1. Шалина Р.И., Спиридонов Д.С., Латышкевич О.А. и др. Спонтанные и индуцированные экстремально ранние преждевременные роды: исходы для детей. Вопросы гинекологии, акушерства и перинатологии. 2018; 17 (2); 54-62 [Shalina R., Spiridonov D., Latyshkevich O. et al. Spontaneous and induced extremely preterm birth: outcomes for children. Voprosy ginekologii, akusherstva i perinatologii. 2018; 17 (2); 54-62 (in Russ.)]. doi: 10.20953/1726-1678-2018-2-54-61
  2. Romero R., Dey S., Fisher S. Preterm labor: one syndrome, many causes. Science. 2014; 345 (6198): 760-5. doi: 10.1126/science.1251816
  3. Ходжаева З.С., Гусейнова Г.Э., Горина К.А. Преждевременные роды: актуальные вопросы акушерского менеджмента. Медицинский оппонент. 2018; 2: 70-6 [Khodzhaeva Z., Guseynova G., Gorina K. Preterm labor: current problems of obstetrics management. Medical opponent. 2018; 2: 70-6 (in Russ.)].
  4. Караулов А.В., Афанасьев М.С., Несвижский Ю.В. и др. Микробные патогены при урогенитальной инфекции беременных. Журн микробиол, эпидемиоли иммунобиол. 2019; 6: 13-20 [Karaulov A., Afanasiev M., Nesvizhsky Yu. et al. Microbial pathogens in urogenital infection in pregnant women. Journal of microbiology, epidemiology and immunobiology. 2019; 6: 13-20 (in Russ.)]. doi: 10.36233/0372-9311-2019-6-13-20
  5. Михалев С.А., Бабиченко И.И., Шахпазян Н.К. и др. Роль урогенитальной инфекции в развитии спонтанных преждевременных родов. Проблемы репродукции. 2019; 25 (2): 93-9 [Mikhalev S., Babichenko I., Shakhpazyan N. et al. Role of urogenital infection in the development of preterm delivery. Problemy reproduktsii. 2019; 25 (2): 93-9 (in Russ)]. doi: 10.17116/repro20192502193
  6. Di. Paola M., Sani C., Clemente A.M. et al. Characterization of cervico-vaginal microbiota in women developing persistent high-risk human papillomavirus infection. SciRep. 2017; 7 (1): 10200. doi: 10.1038/s41598-017-09842-6
  7. Campisciano G., Gheit T., De Seta F. et al. Oncogenic virome benefits from the different vaginal microbiome-immune axes. Microorganisms. 2019; 7 (10): 414. doi: 10.3390/microorganisms7100414
  8. Айламазян Э.К., Шипицына Е.В., Савичева А.М. Микробиота женщины и исходы беременности. Журнал акушерства и женских болезней. 2016; 65 (4): 6-14 [Ailamazian E., Shipitsyna E., Savicheva A. Woman’s microbiota and pregnancy outcomes. Zhurnal akusherstva i zhenskih bolezney. 2016; 65 (4): 6-14 (in Russ.)]. doi: 10.17816/JOWD6546-14
  9. Баранов И.И., Нестерова Л.А., Тумбинская Л.В. Комплексный подход в коррекции экзогенных и эндогенных нарушений микрофлоры влагалища. Opinion Leader. 2018; 1 (2): 54-9 [Baranov I., Nesterova L., Tumbinskaya L. Kompleksnyj podhod v korrekcii jekzogennyh i jendogennyh narushenij mikroflory vlagalishha. Opinion Leader. 2018; 1 (2): 54-9 (in Russ.)].
  10. Royce R.A., Jackson T.P., Thorp J.M. et al. Race/ethnicity, vaginal flora patterns, and pH during pregnancy. Sex Transm Dis. 1999; 26 (2): 96-102. doi: 10.1097/00007435-199902000-00007
  11. Доброхотова Ю.Э., Боровкова Е.И., Хертек С.Е. и др. Бактериальный вагиноз в первом триместре беременности: микробиологические и иммунологические показатели в оценке эффективности терапии. Акушерство и гинекология. 2020; 6: 98-104 [Dobrokhotova Yu., Borovkova E., Hertek S. et al. Bacterial vaginosis in the first trimester of pregnancy: microbiological and immunological indicators in the evaluation of therapy efficiency. Obstetrics and gynecology. 2020; 6: 98-104 (in Russ.)]. doi: 10.18565/aig.2020.6.98-104
  12. Адаскевич В.П. Инфекции, передаваемые половым путем. М.: Медицинская книга, 2001; c. 414 [Adaskevich V. Infekcii, peredavaemye polovym putjom. M.: Medicinskaja kniga, 2001; p. 414 (in Russ.)].
  13. Hillier S.L., Krohn M.A., Rabe L.K. et al. The normal vaginal flora, H2O2-producing lactobacilli, and bacterial vaginosis in pregnant women. Clin Infect Dis. 1993; 16 (S4): S273-81. doi: 10.1093/clinids/16.supplement_4.s273
  14. Ravel J., Gajer P., Abdo Z. et al. Vaginal microbiome of reproductive-age women. Proc Natl Acad Sci USA. 2011; 108 (S1): 4680-7. DOI: 10.1073/ pnas.1002611107
  15. De Seta F., Campisciano G., Zanotta N. et al. The vaginal community state types microbiome-immune network as key factor for bacterial vaginosis and aerobic vaginitis. Front Microbiol. 2019; 10: 2451. doi: 10.3389/fmicb.2019.02451
  16. Parolin C., Marangoni A., Laghi L. et al. Isolation of vaginal lactobacilli and characterization of anti-candida activity. PLoS One. 2015; 10 (6): e0131220. doi: 10.1371/journal.pone.0131220
  17. Хрянин А.А., Кнорринг Г.Ю. Современные представления о биопленках микроорганизмов. Фарматека. 2020; 27 (6): 34-42 [Khryanin A., Knorring G. Modern concepts of microbial biofilms. Pharmateca. 2020; 27 (6): 34-42 (in Russ.)]. doi: 10.18565/pharmateca.2020.6.34-42
  18. Кнорринг Г.Ю., Стернин Ю.И., Минаев С.В. и др. Интенсификация антибактериальной терапии при гнойно-воспалительных заболеваниях. Военномедицинский журнал. 2008; 329 (10): 35-41 [Knorring G., Sternin Yu., Minaev S. et al. Intensification of antibiotic therapy for purulent-inflammatory diseases. Voenno-meditsinskiyzhurnal. 2008; 329 (10): 35-41 (in Russ.)].
  19. Gristina A.G. Biofilms and chronic bacterial infections. Clin Microbiol Newslett. 1994; 16 (22): 171-6. doi: 10.1016/0196-4399(94)90037-X
  20. Romero R., Kusanovic J., Espinoza J. et al. What is amniotic fluid ‘sludge’? ISUOG. 2007; 30: 793-8. doi: 10.1002/uog.5173
  21. Steel J.H., Malatos S., Kennea N. et al. Bacteria and inflammatory cells in fetal membranes do not always cause preterm labor. Pediatr Res. 2005; 57: 404-11.
  22. Fortner K.B., Grotegut C.A., Ransom C.E. et al. Bacteria localization and chorion thinning among preterm premature rupture of membranes. PLoS One. 2014; 9: e83338. doi: 10.1371/journal.pone.0083338
  23. Lee J., Romero R., Kim S. et al. A new anti-microbial combination prolongs the latency period, reduces acute histologic chorioamnionitis as well as funisitis, and improves neonatal outcomes in preterm PROM. J Matern Fetal Neonatal Med. 2016; 29 (5): 707-20. doi: 10.3109/14767058.2015.1020293
  24. Nutten S., Schumann A., Donnicola D. et al. Antibiotic administration early in life impaires specific humoral responses to an oral antigen and increases intestinal mast cell numbers and mediators concentrations. Clin Vaccine Immunol. 2007; 14 (2): 190-7. doi: 10.1128/CVI.00055-06
  25. Mulder I., Schmidt B., Lewis M. et al. Restricting microbial exposure in early life negates the immune benefits associated with gut colonization in environments of high microbial diversity. PLoS One. 2011; 6 (12): e28279-e89. DOI: 10.1371/ journal.pone.0028279
  26. Gueimonde M., Sakata S., Kalliomaki M. et al. Effect of maternal consumption of lactobacillus GG on transfer and establishment of fecal bifidobacterial microbiota in neonates. JPGN. 2006; 42 (2): 166-70. doi: 10.1097/01.mpg.0000189346.25172.fd
  27. Pelucchi C., Chatenoud L., Turati F. et al. Probiotics supplementation during pregnancy or infancy for the prevention of atopic dermatitis: a meta-analysis. Epidemiology. 2012; 23 (3): 402-14. doi: 10.1097/EDE.0b013e31824d5da2
  28. Kuitunen M., Kukkonen A.K., Savilahti E. Impact of maternal allergy and use of probiotics during pregnancy on breast milk cytokines and food antibodies and development of allergy in children until 5 years. Int Arch Allergy Immunol. 2012; 159 (2): 162-70. doi: 10.1159/000336157
  29. Elias J., Bozzo P., Einarson A. Are probiotics safe for use during pregnancy and lactation? Can Fam Phisician. 2011; 57 (3): 299-301.
  30. Honma N., Ohtani К., Kikuchi Н. On effect of lactic acid bacteria. Part II. Clinical effects. New Med Clin. 1987; 36 (1): 75-80
  31. Honma N. On effects of lactic acid bacteria. Part I. Biological significance. New Med Clin. 1986; 35: 2687-95.
  32. Ohno H., Tsunemine S., Isa Y. et al. Oral administration of Bifidobacterium bifi dum G9-1 suppresses total and antigen specifi c immunoglobulin E production in mice. Biol Pharm Bull. 2005; 28 (8): 1462-6. doi: 10.1248/bpb.28.1462
  33. Olivares M., Diaz-Ropero M.P., Gomez N. et al. The consumption of two new probiotic strains, Lactobacillus gasseri CECT 5714 and Lactobacillus coryniformis CECT 5711, boosts the immune system of healthy humans. Int Microbiol. 2006; 9 (1): 47-52
  34. Martinez-Canavate A., Sierra S., Lara-Villoslada F. et al. A probiotic dairy product containing L. gasseri CECT5714 and L. coryniformis CECT5711 induces immunological changes in children suff ering from allergy. Pediatr Allergy Immunol. 2009; 20 (6): 592-600. doi: 10.1111/j.1399-3038.2008.00833.x
  35. Hammer H.F. Colonic hydrogen absorption: quantification of its effect on hydrogen accumulation caused by bacterial fermentation of carbohydrates. Gut. 1993; 34 (6): 818-22. doi: 10.1136/gut.34.6.818

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2021 Russkiy Vrach Publishing House

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies